Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2021

Open Access 01-12-2021 | Ventricular Tachycardia | Case report

Ventricular tachycardia with epicardial and pericardial fibrosis 6 months after resolution of subclinical COVID-19: a case report 

Authors: Jonathan Solaimanzadeh, Aaron Freilich, Michael R Sood

Published in: Journal of Medical Case Reports | Issue 1/2021

Login to get access

Abstract

Background

Coronavirus disease 2019 (COVID-19) has been shown to have extensive effects on the cardiovascular system. Its long-term cardiac manifestations, however, remain unclear.

Case presentation

We report the case of a Caucasian patient with a mild and self-limited presentation of COVID-19, with subsequent development, months later, of exertional dyspnea and non-sustained ventricular tachycardia, long after resolution of his illness and after returning to aerobic exercise. The patient had normal screening tests including electrocardiogram (ECG) and echocardiogram 4 months after his illness. Cardiac magnetic resonance imaging demonstrated epicardial and pericardial fibrosis of the right ventricle free wall and outflow tract and the pericardium over the anterior wall, 6 months following the initial infection. First abnormal ECG was recorded at month 7 following illness.

Conclusions

This case suggests an insidious and possible long-term cardiac involvement and reflects the challenges in traditional workups and screening modalities in identifying cardiac involvement in COVID-19.
Literature
2.
go back to reference Fang LK, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province China. Med J. 2020;133:1025–31.CrossRef Fang LK, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province China. Med J. 2020;133:1025–31.CrossRef
3.
go back to reference Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:1. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:1.
4.
go back to reference Yang X, Yu Y, Xu J, et al. Clinical course and outcome of critically ill patients with SARS-coV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475.CrossRef Yang X, Yu Y, Xu J, et al. Clinical course and outcome of critically ill patients with SARS-coV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8:475.CrossRef
5.
go back to reference Kumar K, Vogt JC, Divanji PH, et al. Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID-19. Catheter Cardiovasc Interv. 2020;146:110410. Kumar K, Vogt JC, Divanji PH, et al. Spontaneous coronary artery dissection of the left anterior descending artery in a patient with COVID-19. Catheter Cardiovasc Interv. 2020;146:110410.
6.
go back to reference Fernandez Gasso L, Maneiro Melon NM. Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection. Eur heart J. 2020;41(32):3100–1.CrossRef Fernandez Gasso L, Maneiro Melon NM. Multivessel spontaneous coronary artery dissection presenting in a patient with severe acute SARS-CoV-2 respiratory infection. Eur heart J. 2020;41(32):3100–1.CrossRef
7.
go back to reference Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associates with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.CrossRef Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associates with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420–2.CrossRef
8.
go back to reference Inciardi RM, Zaccone G, et al. Cardiac Involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819–24.CrossRef Inciardi RM, Zaccone G, et al. Cardiac Involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819–24.CrossRef
9.
go back to reference Dhakal BP, et al. SARS-Cov-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart, lung and Circulation. 2020;29:973–87.CrossRef Dhakal BP, et al. SARS-Cov-2 Infection and Cardiovascular Disease: COVID-19 Heart. Heart, lung and Circulation. 2020;29:973–87.CrossRef
10.
go back to reference Mitra RL, Greenstein SA. An algorithm for managing QT prolongation in coronavirus disease 2019 patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: possible benefits of intravenous lidocaine. Heart Rhythm Case rep. 2020;6:244–8. Mitra RL, Greenstein SA. An algorithm for managing QT prolongation in coronavirus disease 2019 patients treated with either chloroquine or hydroxychloroquine in conjunction with azithromycin: possible benefits of intravenous lidocaine. Heart Rhythm Case rep. 2020;6:244–8.
11.
go back to reference Lal S, Hayward CS, Pasquale CD, et al. COVID-19 and acute heart failure: screening the critically ill. Heart Lung Circ. 2020;29(7):e94-8.CrossRef Lal S, Hayward CS, Pasquale CD, et al. COVID-19 and acute heart failure: screening the critically ill. Heart Lung Circ. 2020;29(7):e94-8.CrossRef
12.
go back to reference Lehrke S, Lossnitzer D, et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart. 2011;97(9):727–32.CrossRef Lehrke S, Lossnitzer D, et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart. 2011;97(9):727–32.CrossRef
13.
go back to reference Tsoumani Z, Miller C, Schmitt M, Nucifora G. 23 Prevalence and correlates of mid-wall late gadolinium enhancement in patients with ischemic cardiomyopathy. Heart. 2019;105(Suppl 3):A20. Tsoumani Z, Miller C, Schmitt M, Nucifora G. 23 Prevalence and correlates of mid-wall late gadolinium enhancement in patients with ischemic cardiomyopathy. Heart. 2019;105(Suppl 3):A20.
14.
go back to reference Green JJ, Salerno M, et al. Prognostic value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy. JACC. 2012;5:370–7.PubMed Green JJ, Salerno M, et al. Prognostic value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy. JACC. 2012;5:370–7.PubMed
15.
go back to reference Alba AC, Gaztanaga J, et al. Prognostic vale of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy, an international, multi-institutional study of the MINICOR Group. Circ Cardiovasc Imaging. 2020;13:4.CrossRef Alba AC, Gaztanaga J, et al. Prognostic vale of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy, an international, multi-institutional study of the MINICOR Group. Circ Cardiovasc Imaging. 2020;13:4.CrossRef
16.
go back to reference Wu KC, Weiss RG, et al. Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy. JACC. 2008;51:25.CrossRef Wu KC, Weiss RG, et al. Late Gadolinium Enhancement by Cardiovascular Magnetic Resonance Heralds an Adverse Prognosis in Nonischemic Cardiomyopathy. JACC. 2008;51:25.CrossRef
17.
go back to reference Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977–85.CrossRef Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48:1977–85.CrossRef
20.
go back to reference Huang L, Zhao P, Tang D, et al. Cardiac Involvement in recovered COVID-19 patients identified by magnetic resonance imaging. JACC Cardiovasc Imaging. 2020. Huang L, Zhao P, Tang D, et al. Cardiac Involvement in recovered COVID-19 patients identified by magnetic resonance imaging. JACC Cardiovasc Imaging. 2020.
21.
go back to reference Delacretaz E, Stevenson WG, Ellison KE, Maisel WH, Friedman PL. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol. 2000;11:11–7.CrossRef Delacretaz E, Stevenson WG, Ellison KE, Maisel WH, Friedman PL. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol. 2000;11:11–7.CrossRef
22.
go back to reference Fernandez-Jimenez R, Sanchez-Gonzalez J, Aguero J, et al. Fast T2 gradient-spin (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion. J Cardiovasc Magn Reson. 2015;17(1):92.CrossRef Fernandez-Jimenez R, Sanchez-Gonzalez J, Aguero J, et al. Fast T2 gradient-spin (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion. J Cardiovasc Magn Reson. 2015;17(1):92.CrossRef
23.
go back to reference Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011;4(3):269–78.CrossRef Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011;4(3):269–78.CrossRef
24.
go back to reference Dabir D, Child N, Kalra, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the international T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014;16(1):69. Dabir D, Child N, Kalra, et al. Reference values for healthy human myocardium using a T1 mapping methodology: results from the international T1 multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2014;16(1):69.
25.
go back to reference Clark DE, et al. COVID-19 Myocardial pathology evaluated through screening cardiac magnetic resonance (COMPETE CMR), preprints from MedRxiv and bioRxiv Clark DE, et al. COVID-19 Myocardial pathology evaluated through screening cardiac magnetic resonance (COMPETE CMR), preprints from MedRxiv and bioRxiv
26.
go back to reference Shafi AMA, Shaikh SA, Shrike NM. Cardiac manifestations in COVID-19 patients- a systemic review. J Card Surg. 2020;35:1988–2008.CrossRef Shafi AMA, Shaikh SA, Shrike NM. Cardiac manifestations in COVID-19 patients- a systemic review. J Card Surg. 2020;35:1988–2008.CrossRef
Metadata
Title
Ventricular tachycardia with epicardial and pericardial fibrosis 6 months after resolution of subclinical COVID-19: a case report 
Authors
Jonathan Solaimanzadeh
Aaron Freilich
Michael R Sood
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2021
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-021-02782-w

Other articles of this Issue 1/2021

Journal of Medical Case Reports 1/2021 Go to the issue